Current:Home > MarketsCOVID variant BA.2.86 triples in new CDC estimates, now 8.8% of cases -Golden Horizon Investments
COVID variant BA.2.86 triples in new CDC estimates, now 8.8% of cases
View
Date:2025-04-26 11:25:29
Nearly 1 in 10 new COVID-19 cases in the U.S. are from the BA.2.86 variant, the Centers for Disease Control and Prevention estimated Monday, nearly triple what the agency estimated the highly mutated variant's prevalence was two weeks ago.
Among the handful of regions with enough specimens reported from testing laboratories, BA.2.86's prevalence is largest in the Northeast: 13.1% of cases in the New York and New Jersey region are blamed on the strain.
Monday's figures mark the first time BA.2.86's prevalence has surged enough to be listed as a standalone variant on the CDC's estimates. Scientists first warned of the highly mutated strain's discovery over the summer.
"In previous Nowcast updates, BA.2.86 was too uncommon to be shown separately and was grouped with other BA.2 strains," the CDC said Monday.
Before this point, officials have said the vast majority of new COVID-19 cases have been blamed on the XBB variant and a crowd of XBB's closely related descendants. Those include the HV.1 and EG.5 variants that are currently predominant nationwide.
The CDC's estimates carry wide margins of error around BA.2.86's prevalence. As little as 4.8% or as much as 15.2% of circulating SARS-CoV-2 could be from BA.2.86, the agency says.
However, this latest estimate – 8.8% through Nov. 25 – is virtually triple what it was on Nov. 11, when 3.0% of new cases were estimated to be BA.2.86. The CDC typically publishes its variant estimates every other Friday, but had delayed last week's release until after the Thanksgiving holiday weekend.
"It is important to note that early projections tend to be less reliable, since they depend on examining growth trends of a smaller number of sequences, especially as laboratory-based testing volume for SARS-CoV-2 has decreased substantially over time," the agency said.
The World Health Organization also recently stepped up its classification of BA.2.86 and its descendants to a "variant of interest" after a rise in cases from the strain.
Early data on BA.2.86 suggests it does not appear to lead to worse or different symptoms than previous strains, the WHO said in its Nov. 21 risk evaluation, but noted a "substantial rise" in recent BA.2.86 reports.
The CDC said it did not disagree with the WHO's assessment that BA.2.86 likely posed a "low" public health risk, adding that for now the strain "BA.2.86 does not appear to be driving increases in infections or hospitalizations in the United States."
It comes as the CDC has begun to track a renewed increase in indicators tracking COVID-19's spread across the U.S. headed into the winter.
After weeks of largely slowing or flat trends, the CDC said this month that figures like emergency department visits had begun to increase nationwide from COVID-19. Virtually all regions of the country are now seeing at least slight increases.
Some of the highest increases are in the Midwestern region covering Illinois, Indiana, Michigan, Minnesota, Ohio and Wisconsin, where trends are nearing levels not seen since early January.
Is the JN.1 variant to blame?
Since August, BA.2.86's broad array of mutations did not appear to be enough for the strain to gain a foothold over XBB and its descendants. Months of the highly mutated variant's spread only resulted in a small share of cases throughout the world.
But scientists in recent weeks have been studying a steep increase in a BA.2.86 descendant called JN.1, which quickly rose to become the fastest-growing subvariant worldwide.
Many cases have been reported in Europe, which has seen increasing cases from BA.2.86 and its descendants.
Authorities in France said on Nov. 13 that JN.1 was largely driving that country's increase in BA.2.86 infections, climbing to 10% of sequences in the country. Early investigations of JN.1 had not turned up any worrying signals so far compared to other BA.2.86 infections, they said, though more in-depth analyses were underway.
Data from recent weeks tallied from the GISAID virus database suggests as much as a third of COVID-19 variants reported from labs in the U.S. have been of JN.1.
"Currently, JN.1 is the most common version of BA.2.86 in the U.S. CDC projects BA.2.86 and its offshoots like JN.1 will continue to increase as a proportion of SARS-CoV-2 genomic sequences," CDC spokesperson Jasmine Reed told CBS News in an email.
Last month, the CDC said it expected COVID-19 tests and treatment would remain effective against JN.1, which is closely related to BA.2.86 aside from a single change to its spike protein that early research suggests is enabling it to spread faster.
This season's vaccines are also expected to work against JN.1 similar to what was estimated for its BA.2.86 parent, the agency said.
- In:
- COVID-19
- Coronavirus
Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers the Biden administration's public health agencies, including the federal response to infectious disease outbreaks like COVID-19.
TwitterveryGood! (3)
Related
- Meet first time Grammy nominee Charley Crockett
- New York, Philadelphia and Washington teams postpone games because of smoke coming from Canadian wildfires
- Today’s Climate: July 19, 2010
- Sum 41 Announces Band's Breakup After 27 Years Together
- Macy's says employee who allegedly hid $150 million in expenses had no major 'impact'
- State legislative races are on the front lines of democracy this midterm cycle
- The story of two bird-saving brothers in India gets an Oscar nom, an HBO premiere
- Abortion is on the California ballot. But does that mean at any point in pregnancy?
- The Best Stocking Stuffers Under $25
- K-9 dog dies after being in patrol car with broken air conditioning, police say
Ranking
- Bodycam footage shows high
- Precious memories: 8 refugees share the things they brought to remind them of home
- Coal’s Latest Retreat: Arch Backs Away From Huge Montana Mine
- It cost $38,398 for a single shot of a very old cancer drug
- 'We're reborn!' Gazans express joy at returning home to north
- Henry Winkler Shares He Had Debilitating Emotional Pain After the End of Happy Days
- Paying for mental health care leaves families in debt and isolated
- Concussion protocols are based on research of mostly men. What about women?
Recommendation
Have Dry, Sensitive Skin? You Need To Add These Gentle Skincare Products to Your Routine
Brain Cells In A Dish Play Pong And Other Brain Adventures
Trump informed he is target of special counsel criminal probe
Selling Sunset's Jason Oppenheim Teases Intense New Season, Plus the Items He Can't Live Without
Spooky or not? Some Choa Chu Kang residents say community garden resembles cemetery
Today’s Climate: July 13, 2010
Orlando Bloom Lights Up Like a Firework Over Katy Perry's Coronation Performance
Health department medical detectives find 84% of U.S. maternal deaths are preventable